• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019 年冠状病毒病的 11 个面孔。

Eleven faces of coronavirus disease 2019.

机构信息

Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China.

出版信息

Allergy. 2020 Jul;75(7):1699-1709. doi: 10.1111/all.14289. Epub 2020 Apr 6.

DOI:10.1111/all.14289
PMID:32196678
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7228397/
Abstract

BACKGROUND AND AIMS

The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has recently spread worldwide and been declared a pandemic. We aim to describe here the various clinical presentations of this disease by examining eleven cases.

METHODS

Electronic medical records of 11 patients with COVID-19 were collected, and demographics, clinical manifestations, outcomes, key laboratory results, and radiological images are discussed.

RESULTS

The clinical course of the eleven cases demonstrated the complexity of the COVID-19 profile with different clinical presentations. Clinical manifestations range from asymptomatic cases to patients with mild and severe symptoms, with or without pneumonia. Laboratory detection of the viral nucleic acid can yield false-negative results, and serological testing of virus-specific IgG and IgM antibodies should be used as an alternative for diagnosis. Patients with common allergic diseases did not develop distinct symptoms and severe courses. Cases with a pre-existing condition of chronic obstructive pulmonary disease or complicated with a secondary bacterial pneumonia were more severe.

CONCLUSION

All different clinical characteristics of COVID-19 should be taken into consideration to identify patients that need to be in strict quarantine for the efficient containment of the pandemic.

摘要

背景与目的

由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染引起的 2019 年冠状病毒病(COVID-19)疫情最近在全球范围内爆发,并已宣布为大流行。我们旨在通过检查 11 例来描述这种疾病的各种临床表现。

方法

收集了 11 例 COVID-19 患者的电子病历,并讨论了人口统计学、临床表现、结局、关键实验室结果和影像学图像。

结果

11 例患者的临床过程表明 COVID-19 具有不同临床表现的复杂性。临床表现从无症状病例到轻度和重度症状病例不等,伴有或不伴有肺炎。病毒核酸的实验室检测可能会产生假阴性结果,应使用病毒特异性 IgG 和 IgM 抗体的血清学检测作为替代诊断。患有常见过敏性疾病的患者没有出现明显的症状和严重的病程。患有慢性阻塞性肺疾病的既往病史或合并继发性细菌性肺炎的患者病情更严重。

结论

应考虑 COVID-19 的所有不同临床特征,以识别需要严格隔离的患者,从而有效控制疫情。

相似文献

1
Eleven faces of coronavirus disease 2019.2019 年冠状病毒病的 11 个面孔。
Allergy. 2020 Jul;75(7):1699-1709. doi: 10.1111/all.14289. Epub 2020 Apr 6.
2
Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.评价两种 SARS-CoV-2 快速 IgM-IgG 联合抗体检测试剂盒在指尖毛细血管全血样本中的性能。
PLoS One. 2020 Sep 17;15(9):e0237694. doi: 10.1371/journal.pone.0237694. eCollection 2020.
3
Value of Viral Nucleic Acid in Sputum and Feces and Specific IgM/IgG in Serum for the Diagnosis of Coronavirus Disease 2019.痰和粪便中的病毒核酸与血清特异性 IgM/IgG 对 2019 年冠状病毒病的诊断价值。
Front Cell Infect Microbiol. 2020 Aug 6;10:445. doi: 10.3389/fcimb.2020.00445. eCollection 2020.
4
Antibody responses to SARS-CoV-2 in patients with COVID-19.新型冠状病毒肺炎(COVID-19)患者的 SARS-CoV-2 抗体反应。
Nat Med. 2020 Jun;26(6):845-848. doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.
5
Kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19: a descriptive study.新型冠状病毒感染临床病程中的病毒学、特异性抗体反应和影像学变化:一项描述性研究。
BMC Infect Dis. 2020 Nov 10;20(1):818. doi: 10.1186/s12879-020-05549-8.
6
Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.新型冠状病毒肺炎患者的抗体检测及动态特征。
Clin Infect Dis. 2020 Nov 5;71(8):1930-1934. doi: 10.1093/cid/ciaa461.
7
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.5 例危重症 COVID-19 患者接受恢复期血浆治疗。
JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.
8
Longitudinal Change of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Patients with Coronavirus Disease 2019.新型冠状病毒病患者严重急性呼吸综合征冠状病毒 2 抗体的纵向变化。
J Infect Dis. 2020 Jun 29;222(2):183-188. doi: 10.1093/infdis/jiaa229.
9
Characteristics of recovered COVID-19 patients with recurrent positive RT-PCR findings in Wuhan, China: a retrospective study.中国武汉新冠病毒核酸检测复阳康复患者的特征:一项回顾性研究
BMC Infect Dis. 2020 Oct 13;20(1):749. doi: 10.1186/s12879-020-05463-z.
10
SARS-CoV-2 lgM/lgG antibody detection confirms the infection after three negative nucleic acid detection.新型冠状病毒(SARS-CoV-2)IgM/IgG 抗体检测可在三次核酸检测阴性后确认感染。
J Cell Mol Med. 2020 Jul;24(14):8262-8265. doi: 10.1111/jcmm.15275. Epub 2020 May 19.

引用本文的文献

1
Assessment of smoking exposure by urine cotinine levels in severe COVID-19 patients: a case-control study.通过尿可替宁水平评估重症 COVID-19 患者的吸烟暴露情况:一项病例对照研究。
Sci Rep. 2025 Aug 28;15(1):31696. doi: 10.1038/s41598-025-17768-7.
2
Fusion protein-based COVID-19 vaccines exemplified by a chimeric vaccine based on a single fusion protein (W-PreS-O).以基于单一融合蛋白(W-PreS-O)的嵌合疫苗为代表的基于融合蛋白的新冠疫苗。
Front Immunol. 2025 Jan 28;16:1452814. doi: 10.3389/fimmu.2025.1452814. eCollection 2025.
3
Impact of SARS-CoV-2 infection on patients with myasthenia gravis: a retrospective study in a Chinese population.新型冠状病毒2019感染对重症肌无力患者的影响:一项中国人群的回顾性研究
Front Neurol. 2024 Dec 11;15:1482932. doi: 10.3389/fneur.2024.1482932. eCollection 2024.
4
Dynamic changes of hematological and hemostatic parameters in COVID-19 hospitalized patients: Potential role as severity biomarkers for the Chilean population.新冠病毒肺炎住院患者血液学和止血参数的动态变化:对智利人群作为疾病严重程度生物标志物的潜在作用
J Med Biochem. 2024 Jun 15;43(4):556-564. doi: 10.5937/jomb0-47588.
5
The Effect of Coronavirus Disease 2019 on the Quality of Associated Care in Patients with Gastric Cancer.2019年冠状病毒病对胃癌患者相关护理质量的影响。
Middle East J Dig Dis. 2024 Jan;16(1):12-22. doi: 10.34172/mejdd.2024.363. Epub 2024 Jan 31.
6
The liver-to-spleen ratio is a risk factor predicting oxygen demand in COVID-19 patients.肝脾比是预测新冠病毒肺炎患者氧气需求的一个风险因素。
Infect Med (Beijing). 2023 Jun;2(2):105-111. doi: 10.1016/j.imj.2023.04.002. Epub 2023 Apr 20.
7
A cross-sectional study in critically ill patients affected by COVID-19 in an intensive care unit: would resistant to carbapenems be the biggest villain?在一家重症监护病房对感染新冠病毒的危重症患者进行的横断面研究:碳青霉烯类耐药会是最大的“罪魁祸首”吗?
Access Microbiol. 2023 Oct 18;5(10). doi: 10.1099/acmi.0.000542.v3. eCollection 2023.
8
Interleukin-6 and Its Soluble Receptor Complex in Intensive Care Unit COVID-19 Patients: An Analysis of Second Wave Patients.重症监护病房新冠肺炎患者中的白细胞介素-6及其可溶性受体复合物:对第二波患者的分析
Pathogens. 2023 Oct 20;12(10):1264. doi: 10.3390/pathogens12101264.
9
GEMA 5.3. Spanish Guideline on the Management of Asthma.GEMA 5.3. 《西班牙哮喘管理指南》。
Open Respir Arch. 2023 Sep 19;5(4):100277. doi: 10.1016/j.opresp.2023.100277. eCollection 2023 Oct-Dec.
10
An atypical presentation of COVID-19: Hidden risk for seniors to misdiagnose.新冠肺炎的非典型表现:老年人误诊的潜在风险。
North Clin Istanb. 2023 Aug 4;10(4):521-523. doi: 10.14744/nci.2022.35336. eCollection 2023.

本文引用的文献

1
On the origin and continuing evolution of SARS-CoV-2.关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的起源及持续进化
Natl Sci Rev. 2020 Jun;7(6):1012-1023. doi: 10.1093/nsr/nwaa036. Epub 2020 Mar 3.
2
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
3
Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding.儿童感染 SARS-CoV-2 的特征及粪便中持续存在病毒的潜在证据。
Nat Med. 2020 Apr;26(4):502-505. doi: 10.1038/s41591-020-0817-4. Epub 2020 Mar 13.
4
Polymerase Chain Reaction Assays Reverted to Positive in 25 Discharged Patients With COVID-19.25名新冠病毒病出院患者的聚合酶链反应检测结果复阳。
Clin Infect Dis. 2020 Nov 19;71(16):2230-2232. doi: 10.1093/cid/ciaa398.
5
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
6
Detection of SARS-CoV-2 in Different Types of Clinical Specimens.SARS-CoV-2 在不同类型临床标本中的检测。
JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.
7
Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China.中国南京接触者中 24 例新冠肺炎无症状感染的临床特征。
Sci China Life Sci. 2020 May;63(5):706-711. doi: 10.1007/s11427-020-1661-4. Epub 2020 Mar 4.
8
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.严重急性呼吸综合征相关冠状病毒:将 2019-nCoV 进行分类并命名为 SARS-CoV-2。
Nat Microbiol. 2020 Apr;5(4):536-544. doi: 10.1038/s41564-020-0695-z. Epub 2020 Mar 2.
9
Asymptomatic novel coronavirus pneumonia patient outside Wuhan: The value of CT images in the course of the disease.武汉外的无症状新型冠状病毒肺炎患者:疾病过程中 CT 图像的价值。
Clin Imaging. 2020 Jul;63:7-9. doi: 10.1016/j.clinimag.2020.02.008. Epub 2020 Feb 22.
10
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.